191 related articles for article (PubMed ID: 6908606)
1. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
Moore FD; Fearon DT; Austen KF
J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
[No Abstract] [Full Text] [Related]
2. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
Kaneko I; Fearon DT; Austen KF
J Immunol; 1980 Mar; 124(3):1194-8. PubMed ID: 6898640
[No Abstract] [Full Text] [Related]
4. Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement.
Nelson B; Ruddy S
J Immunol; 1979 May; 122(5):1994-9. PubMed ID: 376729
[No Abstract] [Full Text] [Related]
5. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.
Kazatchkine MD; Fearon DT; Austen KF
J Immunol; 1979 Jan; 122(1):75-81. PubMed ID: 762425
[No Abstract] [Full Text] [Related]
6. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
[No Abstract] [Full Text] [Related]
7. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
[TBL] [Abstract][Full Text] [Related]
8. Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.
Gadd KJ; Reid KB
Immunology; 1981 Jan; 42(1):75-82. PubMed ID: 6780451
[TBL] [Abstract][Full Text] [Related]
9. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
Isenman DE; Podack ER; Cooper NR
J Immunol; 1980 Jan; 124(1):326-31. PubMed ID: 7350230
[TBL] [Abstract][Full Text] [Related]
10. How naturally occurring anti-band 3 antibodies stimulate C3b deposition to senescent and oxidatively stressed red blood cells.
Lutz HU; Stammler P; Fasler S
Biomed Biochim Acta; 1990; 49(2-3):S224-9. PubMed ID: 2386510
[TBL] [Abstract][Full Text] [Related]
11. [Complement: mechanisms of activation, functions, analysis].
Dessaint JP; Wattre P; Santoro F; Capron A
Lille Med; 1979; 24(7):551-8. PubMed ID: 397392
[No Abstract] [Full Text] [Related]
12. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system].
Lesavre P; Leibowitch J
Nouv Presse Med; 1979 Jun; 8(29):2385-7. PubMed ID: 493022
[No Abstract] [Full Text] [Related]
13. Activation of the alternative complement pathway by the immune precipitate formed with F(ab')2 fragment of human IgG antibody.
Akagaki Y; Inai S
Mol Immunol; 1983 Nov; 20(11):1221-6. PubMed ID: 6419059
[TBL] [Abstract][Full Text] [Related]
14. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
[TBL] [Abstract][Full Text] [Related]
15. An affinity for complement C3 as a possible reason for the potency of naturally occurring antibodies in mediating tissue homeostasis.
Lutz HU; Fasler S; Stammler P
Beitr Infusionsther; 1989; 24():193-9. PubMed ID: 2481539
[TBL] [Abstract][Full Text] [Related]
16. How immune complexes from certain IgG NAbs and any F(ab')₂ can mediate excessive complement activation.
Lutz HU
Adv Exp Med Biol; 2012; 750():186-96. PubMed ID: 22903675
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
Strunk RC; Giclas PC
J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
[No Abstract] [Full Text] [Related]
19. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
Leist-Welsh P; Bjornson AB
J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
[No Abstract] [Full Text] [Related]
20. Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.
Boxx GM; Nishiya CT; Kozel TR; Zhang MX
Mol Immunol; 2009 Jan; 46(3):473-80. PubMed ID: 19038459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
